Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Short term Debt (2022 - 2024)

Historic Short term Debt for Roivant Sciences (ROIV) over the last 3 years, with Q2 2024 value amounting to $12.0 million.

  • Roivant Sciences' Short term Debt fell 7297.66% to $12.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $12.0 million, marking a year-over-year decrease of 7297.66%. This contributed to the annual value of $12.0 million for FY2024, which is 7053.05% down from last year.
  • Roivant Sciences' Short term Debt amounted to $12.0 million in Q2 2024, which was down 7297.66% from $12.0 million recorded in Q1 2024.
  • Over the past 5 years, Roivant Sciences' Short term Debt peaked at $49.0 million during Q3 2023, and registered a low of $12.0 million during Q1 2024.
  • Its 3-year average for Short term Debt is $34.5 million, with a median of $37.7 million in 2022.
  • In the last 5 years, Roivant Sciences' Short term Debt skyrocketed by 3704.2% in 2023 and then crashed by 7297.66% in 2024.
  • Quarter analysis of 3 years shows Roivant Sciences' Short term Debt stood at $37.7 million in 2022, then grew by 21.16% to $45.7 million in 2023, then tumbled by 73.75% to $12.0 million in 2024.
  • Its last three reported values are $12.0 million in Q2 2024, $12.0 million for Q1 2024, and $45.7 million during Q4 2023.